C07K 5/0812
And aromatic or cycloaliphatic
Official title: {and aromatic or cycloaliphatic}
C07K5/0812 (And aromatic or cycloaliphatic) appears on 697 US grants and 710 published applications in this corpus.
Search patents in C07K- Granted patents
- 697
- Published applications
- 710
- Assignees
- 443
- Inventors
- 1,910
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 13 | 0 |
| 1981 | 13 | 0 |
| 1982 | 12 | 0 |
| 1983 | 3 | 0 |
| 1984 | 10 | 0 |
| 1985 | 7 | 0 |
| 1986 | 2 | 0 |
| 1987 | 7 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 6 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 19 | 0 |
| 1998 | 25 | 0 |
| 1999 | 13 | 0 |
| 2000 | 22 | 0 |
| 2001 | 19 | 1 |
| 2002 | 17 | 11 |
| 2003 | 9 | 28 |
| 2004 | 12 | 20 |
| 2005 | 9 | 22 |
| 2006 | 20 | 27 |
| 2007 | 19 | 40 |
| 2008 | 13 | 35 |
| 2009 | 21 | 46 |
| 2010 | 25 | 49 |
| 2011 | 17 | 25 |
| 2012 | 34 | 40 |
| 2013 | 34 | 36 |
| 2014 | 29 | 32 |
| 2015 | 29 | 28 |
| 2016 | 23 | 38 |
| 2017 | 25 | 37 |
| 2018 | 19 | 26 |
| 2019 | 18 | 25 |
| 2020 | 19 | 28 |
| 2021 | 26 | 23 |
| 2022 | 13 | 21 |
| 2023 | 6 | 22 |
| 2024 | 20 | 25 |
| 2025 | 15 | 15 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Composition and method for HIP1-targeting inhibitor compounds21 Apr 2026US 12,605,456 B2Utah Valley University
- Levorphanol prodrugs and processes for making and using them31 Mar 2026US 12,590,065 B2Zevra Therapeutics, Inc.
- Method for producing peptide compound20 Jan 2026US 12,528,834 B2Nissan Chemical Corporation
- Riluzole prodrugs and their use18 Nov 2025US 12,472,165 B2Biohaven Therapeutics Ltd.
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Peptides comprising thioester groups, including depsipeptide thioesters, methods of making, and use thereof6 Aug 2026US 2026/0224715 A1Brandeis University
- Radiolabeled medicine30 Jul 2026US 2026/0216383 A1National University Corporation Chiba University
- Cationic cross-linked vesicles23 Jul 2026US 2026/0207772 A1Bracco Suisse SA
Most cited
By later US patents
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995
- Hypotensive peptides and their use161US 4,548,926 ASankyo Company, Limited · 1985
- Hepatitis C inhibitor tri-peptides134US 6,323,180 B1Boehringer Ingelheim (Canada) Ltd. · 2001
- Hepatitis C inhibitor tri-peptides118US 6,534,523 B1Boehringer Ingelheim (Canada) Ltd. · 2003